133 related articles for article (PubMed ID: 31944614)
21. Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.
Hermanns-Clausen M; Müller D; Kithinji J; Angerer V; Franz F; Eyer F; Neurath H; Liebetrau G; Auwärter V
Clin Toxicol (Phila); 2018 Jun; 56(6):404-411. PubMed ID: 29072524
[TBL] [Abstract][Full Text] [Related]
22. Fatal intoxication of a regular drug user following N-ethyl-hexedrone and ADB-FUBINACA consumption.
Kovács K; Kereszty É; Berkecz R; Tiszlavicz L; Sija É; Körmöczi T; Jenei N; Révész-Schmehl H; Institóris L
J Forensic Leg Med; 2019 Jul; 65():92-100. PubMed ID: 31128567
[TBL] [Abstract][Full Text] [Related]
23. Case Report: Synthetic Cannabinoid Deaths in State of Florida Prisoners.
Hvozdovich JA; Chronister CW; Logan BK; Goldberger BA
J Anal Toxicol; 2020 Apr; 44(3):298-300. PubMed ID: 31776572
[TBL] [Abstract][Full Text] [Related]
24. Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA.
Banister SD; Moir M; Stuart J; Kevin RC; Wood KE; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Glass M; Connor M; McGregor IS; Kassiou M
ACS Chem Neurosci; 2015 Sep; 6(9):1546-59. PubMed ID: 26134475
[TBL] [Abstract][Full Text] [Related]
25. The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolism.
Finlay DB; Mackie W; Webb HDJ; Thomsen LR; Nimick M; Rosengren RJ; Marusich JA; Glass M; Wiley JL
Pharmacol Biochem Behav; 2023 Feb; 223():173530. PubMed ID: 36805861
[TBL] [Abstract][Full Text] [Related]
26. In-depth comparison of the metabolic and pharmacokinetic behaviour of the structurally related synthetic cannabinoids AMB-FUBINACA and AMB-CHMICA in rats.
Fabregat-Safont D; Mata-Pesquera M; Barneo-Muñoz M; Martinez-Garcia F; Mardal M; Davidsen AB; Sancho JV; Hernández F; Ibáñez M
Commun Biol; 2022 Feb; 5(1):161. PubMed ID: 35210552
[TBL] [Abstract][Full Text] [Related]
27. UPLC/ESI-MS/MS-based determination of metabolism of several new illicit drugs, ADB-FUBINACA, AB-FUBINACA, AB-PINACA, QUPIC, 5F-QUPIC and α-PVT, by human liver microsome.
Takayama T; Suzuki M; Todoroki K; Inoue K; Min JZ; Kikura-Hanajiri R; Goda Y; Toyo'oka T
Biomed Chromatogr; 2014 Jun; 28(6):831-8. PubMed ID: 24861751
[TBL] [Abstract][Full Text] [Related]
28. Stability of Synthetic Cannabinoids in Biological Specimens: Analysis Through Liquid Chromatography Tandem Mass Spectrometry.
Fort C; Jourdan T; Jesse Kemp ; Curtis B
J Anal Toxicol; 2017 Jun; 41(5):360-366. PubMed ID: 28334817
[TBL] [Abstract][Full Text] [Related]
29. In Vitro Phase I Metabolic Profiling of the Synthetic Cannabinoids AM-694, 5F-NNEI, FUB-APINACA, MFUBINAC, and AMB-FUBINACA.
Apirakkan O; Gavrilović I; Cowan DA; Abbate V
Chem Res Toxicol; 2020 Jul; 33(7):1653-1664. PubMed ID: 32301604
[TBL] [Abstract][Full Text] [Related]
30.
Carlier J; Diao X; Wohlfarth A; Scheidweiler K; Huestis MA
Curr Neuropharmacol; 2017 Jul; 15(5):682-691. PubMed ID: 29403341
[TBL] [Abstract][Full Text] [Related]
31. Identification and quantification of metabolites of AB-CHMINACA in a urine specimen of an abuser.
Wurita A; Hasegawa K; Minakata K; Gonmori K; Nozawa H; Yamagishi I; Suzuki O; Watanabe K
Leg Med (Tokyo); 2016 Mar; 19():113-8. PubMed ID: 26257317
[TBL] [Abstract][Full Text] [Related]
32. Post-aggression suicide under the influence of new psychoactive substances AMB-FUBINACA and U-47700.
Romańczuk A; Rojek S; Kula K; Maciów-Głąb M; Synowiec K; Moskała A; Rzepecka-Woźniak E; Kłys M
Leg Med (Tokyo); 2022 May; 56():102053. PubMed ID: 35279624
[TBL] [Abstract][Full Text] [Related]
33. A case of intoxication with a mixture of synthetic cannabinoids EAM-2201, AB-PINACA and AB-FUBINACA, and a synthetic cathinone α-PVP.
Yamagishi I; Minakata K; Nozawa H; Hasegawa K; Suzuki M; Kitamoto T; Suzuki O; Watanabe K
Leg Med (Tokyo); 2018 Nov; 35():44-49. PubMed ID: 30268690
[TBL] [Abstract][Full Text] [Related]
34. Oral Fluid vs. Urine Analysis to Monitor Synthetic Cannabinoids and Classic Drugs Recent Exposure.
Blandino V; Wetzel J; Kim J; Haxhi P; Curtis R; Concheiro M
Curr Pharm Biotechnol; 2017; 18(10):796-805. PubMed ID: 29173162
[TBL] [Abstract][Full Text] [Related]
35. A Fast and Comprehensive Analysis of 32 Synthetic Cannabinoids Using Agilent Triple Quadrupole LC-MS-MS.
Borg D; Tverdovsky A; Stripp R
J Anal Toxicol; 2017 Jan; 41(1):6-16. PubMed ID: 27681343
[TBL] [Abstract][Full Text] [Related]
36. Do you feel it now? Route of administration and Δ
Wiley JL; Lefever TW; Glass M; Thomas BF
Neurotoxicology; 2019 Jul; 73():161-167. PubMed ID: 30953678
[TBL] [Abstract][Full Text] [Related]
37. Characterisation of AMB-FUBINACA metabolism and CB
Webb HDJ; Finlay DB; Chen S; Vernall AJ; Sparkes E; Banister SD; Rosengren RJ; Glass M
Forensic Toxicol; 2023 Jan; 41(1):114-125. PubMed ID: 36652070
[TBL] [Abstract][Full Text] [Related]
38. Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015.
Abouchedid R; Hudson S; Thurtle N; Yamamoto T; Ho JH; Bailey G; Wood M; Sadones N; Stove CP; Dines A; Archer JRH; Wood DM; Dargan PI
Clin Toxicol (Phila); 2017 Jun; 55(5):338-345. PubMed ID: 28421836
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography-tandem mass spectrometry - A New Zealand perspective of use in 2018.
Ong RS; Kappatos DC; Russell SGG; Poulsen HA; Banister SD; Gerona RR; Glass M; Johnson CS; McCarthy MJ
Drug Test Anal; 2020 Feb; 12(2):195-214. PubMed ID: 31595682
[TBL] [Abstract][Full Text] [Related]
40. Detection and quantification of 5F-ADB and its methyl ester hydrolysis metabolite in fatal intoxication cases by liquid chromatography-high resolution mass spectrometry.
Yeter O; Erol Öztürk Y
Forensic Sci Int; 2019 Sep; 302():109866. PubMed ID: 31302415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
